FDA recall record

Thera Test Laboratories EL-Anti-SARS-CoV-2 IgM Kit, Catalog #104-129, IVD recall — FDA Z-2381-2021

Device did not meet the updated EUA packet requirements for positive percent agreement, thus, not adequately validated. Submitted as EUA202129

Class IIclassification
Z-2381-2021official record ID
Sep 8, 2021report date

Recall record at a glance

Official recordZ-2381-2021
CategoryMedical Device Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmThera Test Laboratories, Inc.
Report dateSep 8, 2021
Recall initiation dateJul 30, 2020
Quantity11 kits
LocationLombard, IL, United States

Official product description

EL-Anti-SARS-CoV-2 IgM Kit, Catalog #104-129, IVD. Submitted as EUA202129

Why the product was recalled

Device did not meet the updated EUA packet requirements for positive percent agreement, thus, not adequately validated. Submitted as EUA202129

Distribution information

US Nationwide distribution in the states of CA, FL, IL, IN, NC, and TX.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.